SLC5A2 and acute kidney injury: The univariable logistic regression analysis showed that only SGLT2-i therapy (OR: 0.36, 95% CI: 0.15–0.82, p = 0.019) was an independent protective factor of CI-AKI for patients undergoing PCI, and this result was also confirmed by the multivariable logistic regression analysis (OR: 0.41, 95% CI: 0.16–0.90, p = 0.045) (Table 3).